Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab

DOI: 10.1080/2162402X.2017.1363138

Keywords: immunotherapy, MVA, p53, PD-1, pembrolizumab, triple negative breast cancer, T cell response, vaccine, vaccinia

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text